Literature DB >> 18250170

Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.

Zhenqiang Yao1, Lianping Xing, Chunlin Qin, Edward M Schwarz, Brendan F Boyce.   

Abstract

Interleukin-1 (IL-1) and tumor necrosis factor (TNF) mediate bone resorption in a variety of diseases affecting bone. Like TNF, IL-1 is secreted by osteoclast precursors (OCPs), but unlike TNF, it does not induce osteoclast formation directly from OCPs in vitro. TNF induces IL-1 expression and activates c-Fos, a transcription factor required in OCPs for osteoclast formation. Here, we examined whether IL-1 can induce osteoclast formation directly from OCPs overexpressing c-Fos and whether interaction with bone matrix affects OCP cytokine expression. We infected OCPs with c-Fos or green fluorescent protein retrovirus, cultured them with macrophage colony-stimulating factor and IL-1 on bone slices or plastic dishes, and assessed osteoclast and resorption pit formation and expression of IL-1 by OCPs. We used a Transwell assay to determine whether OCPs secrete IL-1 when they interact with bone matrix. IL-1 induced osteoclast formation directly from c-Fos-expressing OCPs on plastic. c-Fos-expressing OCPs formed osteoclasts spontaneously on bone slices without addition of cytokines. OCPs on bone secreted IL-1, which induced osteoclast formation from c-Fos-expressing OCPs in the lower Transwell dishes. The bone matrix proteins dentin sialoprotein and osteopontin, but not transforming growth factor-beta, stimulated OCP expression of IL-1 and induced c-Fos-expressing OCP differentiation into osteoclasts. Osteoclasts eroding inflamed joints have higher c-Fos expression compared with osteoclasts inside bone. We conclude that OCPs expressing c-Fos may induce their differentiation directly into osteoclasts by an autocrine mechanism in which they produce IL-1 through interaction with bone matrix. TNF could induce c-Fos expression in OCPs at sites of inflammation in bone to promote this autocrine mechanism and thus amplify bone loss.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250170      PMCID: PMC2442286          DOI: 10.1074/jbc.M706415200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Osteoclasts, integrins, and osteoporosis.

Authors:  S L Teitelbaum
Journal:  J Bone Miner Metab       Date:  2000       Impact factor: 2.626

Review 2.  Reaching a genetic and molecular understanding of skeletal development.

Authors:  Gerard Karsenty; Erwin F Wagner
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

3.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

4.  Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.

Authors:  K Matsuo; J M Owens; M Tonko; C Elliott; T J Chambers; E F Wagner
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

5.  IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways.

Authors:  Zang Hee Lee; Shee Eun Lee; Chang-Woo Kim; Sang Ho Lee; Si Wouk Kim; KyuBum Kwack; Kenneth Walsh; Hong-Hee Kim
Journal:  J Biochem       Date:  2002-01       Impact factor: 3.387

6.  Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin.

Authors:  L W Fisher; D A Torchia; B Fohr; M F Young; N S Fedarko
Journal:  Biochem Biophys Res Commun       Date:  2001-01-19       Impact factor: 3.575

7.  Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers.

Authors:  E M Hauge; D Qvesel; E F Eriksen; L Mosekilde; F Melsen
Journal:  J Bone Miner Res       Date:  2001-09       Impact factor: 6.741

8.  RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Koichi Matsuo; Hiroshi Suzuki; Tomohiko Suzuki; Kojiro Sato; Taeko Yokochi; Hiromi Oda; Kozo Nakamura; Nobutaka Ida; Erwin F Wagner; Tadatsugu Taniguchi
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

9.  Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin.

Authors:  M Ishijima; S R Rittling; T Yamashita; K Tsuji; H Kurosawa; A Nifuji; D T Denhardt; M Noda
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

10.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  41 in total

1.  Cytokine expression and accelerated tooth movement.

Authors:  C C Teixeira; E Khoo; J Tran; I Chartres; Y Liu; L M Thant; I Khabensky; L P Gart; G Cisneros; M Alikhani
Journal:  J Dent Res       Date:  2010-07-16       Impact factor: 6.116

2.  VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.

Authors:  Qian Zhang; Ruolin Guo; Yan Lu; Lan Zhao; Quan Zhou; Edward M Schwarz; Jing Huang; Di Chen; Zheng-Gen Jin; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

Review 3.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 4.  Cellular and Molecular Pathways Leading to External Root Resorption.

Authors:  A Iglesias-Linares; J K Hartsfield
Journal:  J Dent Res       Date:  2016-11-05       Impact factor: 6.116

5.  Deletion of calponin 2 in macrophages attenuates the severity of inflammatory arthritis in mice.

Authors:  Qi-Quan Huang; M Moazzem Hossain; Wen Sun; Lianping Xing; Richard M Pope; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

6.  Inhibition of osteoclastogenesis by stem cell-derived extracellular matrix through modulation of intracellular reactive oxygen species.

Authors:  Mao Li; Xi Chen; Jinku Yan; Long Zhou; Yifan Wang; Fan He; Jun Lin; Caihong Zhu; Guoqing Pan; Jia Yu; Ming Pei; Huilin Yang; Tao Liu
Journal:  Acta Biomater       Date:  2018-03-08       Impact factor: 8.947

7.  RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.

Authors:  Zhenqiang Yao; Wei Lei; Rong Duan; Yanyun Li; Lu Luo; Brendan F Boyce
Journal:  J Biol Chem       Date:  2017-04-24       Impact factor: 5.157

8.  Bovine dentine organic matrix down-regulates osteoclast activity.

Authors:  Wantida Sriarj; Kazuhiro Aoki; Keiichi Ohya; Yuzo Takagi; Hitoyata Shimokawa
Journal:  J Bone Miner Metab       Date:  2009-03-20       Impact factor: 2.626

9.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 10.  Osteoclasts have multiple roles in bone in addition to bone resorption.

Authors:  Brendan F Boyce; Zhenqiang Yao; Lianping Xing
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.